» Authors » Thomas C Lauenstein

Thomas C Lauenstein

Explore the profile of Thomas C Lauenstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 108
Citations 1498
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lauenstein T
Eur Radiol . 2020 May; 30(10):5367-5369. PMID: 32435927
No abstract available.
2.
Laader A, Beiderwellen K, Kraff O, Maderwald S, Wrede K, Ladd M, et al.
PLoS One . 2017 Nov; 12(11):e0187528. PMID: 29125850
Objectives: The aim of this study was to investigate and compare the feasibility as well as potential impact of altered magnetic field properties on image quality and potential artifacts of...
3.
Kirchner J, Sawicki L, Deuschl C, Gruneisen J, Beiderwellen K, Lauenstein T, et al.
PLoS One . 2017 Jul; 12(7):e0180349. PMID: 28683109
Objectives: To evaluate the added value of the application of the liver-specific contrast phase of Gadobenate dimeglumine (Gd-BOPTA) for detection and characterization of liver lesions in 18F-FDG PET/MRI. Methods: 41...
4.
Beiderwellen K, Kraff O, Laader A, Maderwald S, Orzada S, Ladd M, et al.
Eur J Radiol . 2016 Dec; 86:76-82. PMID: 28027770
Objectives: To investigate whether a dose reduction of Gadobutrol for renal magnetic resonance angiography (MRA) at 7 Tesla (T) is feasible while preserving diagnostic image quality. Methods: Ten healthy volunteers...
5.
Beiderwellen K, Kinner S, Gomez B, Lenga L, Bellendorf A, Heusch P, et al.
Eur J Radiol . 2016 Jan; 85(2):414-21. PMID: 26781147
Purpose: To implement a protocol for PET/MR enterography for a multimodal assessment of intestinal pathologies. Materials And Methods: 19 patients with bowel malignancies, Crohn's disease or fever of unknown origin...
6.
Hahnemann M, Kraff O, Maderwald S, Johst S, Orzada S, Umutlu L, et al.
Magn Reson Imaging . 2016 Jan; 34(5):668-73. PMID: 26747410
Objective: To perform non-enhanced (NE) magnetic resonance imaging (MRI) of the small bowel at 7 Tesla (7T) and to compare it with 1.5 Tesla (1.5T). Material And Methods: Twelve healthy...
7.
Theysohn J, Ruhlmann M, Muller S, Dechene A, Best J, Haubold J, et al.
PLoS One . 2015 Sep; 10(9):e0137587. PMID: 26335790
Purpose: Selective Internal Radiation Therapy (SIRT) with 90yttrium (Y-90) is an increasingly used therapeutic option for unresectable liver malignancies. Nontarget embolization of extrahepatic tissue secondary to vascular shunting can lead...
8.
Beiderwellen K, Geraldo L, Ruhlmann V, Heusch P, Gomez B, Nensa F, et al.
PLoS One . 2015 Sep; 10(9):e0137285. PMID: 26335246
Background: The aim of this study was to compare the diagnostic accuracy of [18F]FDG-PET/MRI with PET/CT for the detection of liver metastases. Methods: 32 patients with solid malignancies underwent [18F]FDG-PET/CT...
9.
Lazik A, Landgraeber S, Classen T, Kraff O, Lauenstein T, Theysohn J
Skeletal Radiol . 2015 Jun; 44(10):1467-75. PMID: 26093539
Objective: To analyze remodeling processes after advanced core decompression (ACD) in patients with avascular femoral head necrosis by means of 3T MRI and to identify indicators for clinical outcome considering...
10.
Hahnemann M, Kraff O, Orzada S, Umutlu L, Kinner S, Ladd M, et al.
Invest Radiol . 2015 May; 50(8):539-47. PMID: 25945458
Objectives: T1-weighted (T1w) contrast-enhanced magnetic resonance imaging (MRI) of the small bowel at 1.5 T magnetic field strength has become a standard technique in investigating diseases of the small bowel....